These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 22261518)

  • 1. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rosenblatt J; Venezia R; Gorbach SL; Queenan AM; Hecht DW
    Anaerobe; 2011 Aug; 17(4):147-51. PubMed ID: 21664469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
    Treviño M; Navarro D; Barbeito G; García-Riestra C; Crespo C; Regueiro BJ
    Microb Drug Resist; 2011 Sep; 17(3):433-42. PubMed ID: 21568752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
    Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
    Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories.
    Cordovana M; Kostrzewa M; Sóki J; Witt E; Ambretti S; Pranada AB
    Anaerobe; 2018 Dec; 54():246-253. PubMed ID: 29626622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
    Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
    Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
    Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
    Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
    Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
    Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
    Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
    Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
    Jeverica S; Sóki J; Premru MM; Nagy E; Papst L
    Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Jeong SH; Lee K; Kim JM; Chong Y
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):343-8. PubMed ID: 20226324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of carbapenemase activities of Bacteroides fragilis strains with matrix-assisted laser desorption ionization--time of flight mass spectrometry (MALDI-TOF MS).
    Johansson A; Nagy E; Sóki J;
    Anaerobe; 2014 Apr; 26():49-52. PubMed ID: 24480431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.
    Wallace MJ; Jean S; Wallace MA; Burnham CD; Dantas G
    mBio; 2022 Feb; 13(1):e0360321. PubMed ID: 35038926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a carbapenemase-producing clinical isolate of Bacteroides fragilis in Scandinavia: genetic analysis of a unique insertion sequence.
    Walsh TR; Onken A; Haldorsen B; Toleman MA; Sundsfjord A
    Scand J Infect Dis; 2005; 37(9):676-9. PubMed ID: 16126569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.